[ad_1] Type ‘dog longevity podcast’ into any app and you’ll find comedians, YouTubers and tech billionaires musing about miracle drugs…

[ad_1] If you scroll even a little bit of entrepreneurial social media, you’ll no doubt be familiar with the idea…

[ad_1] Turning water and air into fertiliser sounds like alchemy, but for ATOME it is almost within reach.The AIM-quoted company…

[ad_1] It was a bruising week for investors in genedrive, though hopefully it is a case of short-term pain for…

[ad_1] Litigation Capital Management has suffered a torrid 2025, with its shares tumbling almost 70 per cent after a run…

[ad_1] ImmuPharma has lit up the market with its shares climbing 572 per cent in the last month.While they started…

[ad_1] More than one small-cap pharma share saw a breakthrough in the past week, with some key approvals and news…

[ad_1] Greatland Resources has been one of AIM’s big success stories, proof that it is possible to build a near-£2billion…

[ad_1] Oil, gold and Bitcoin rarely appear in the same sentence. Yet this week, London’s small-cap companies have made them…

[ad_1] Great Scott! Is it 2012 again, or did I just hit 88 miles per hour in a DeLorean?This week’s…